Compare CSQ & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CSQ | VERA |
|---|---|---|
| Founded | 2003 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.0B |
| IPO Year | 2004 | 2021 |
| Metric | CSQ | VERA |
|---|---|---|
| Price | $20.97 | $34.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $81.30 |
| AVG Volume (30 Days) | 149.9K | ★ 2.4M |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 7.53% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $472.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.41 | $23.05 |
| 52 Week High | $21.17 | $56.05 |
| Indicator | CSQ | VERA |
|---|---|---|
| Relative Strength Index (RSI) | 55.79 | 50.23 |
| Support Level | $20.49 | $33.43 |
| Resistance Level | $21.16 | $36.89 |
| Average True Range (ATR) | 0.25 | 1.97 |
| MACD | -0.03 | -0.05 |
| Stochastic Oscillator | 80.17 | 48.74 |
Calamos Strategic Total Return Fund is a diversified, closed-end management investment company. The fund's objective is to provide total return through a combination of capital appreciation and current income. Its investment portfolio comprises equities, convertible securities, and high-yield corporate bonds.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.